Antenatal Intravenous Immunoglobulin (IVIG) therapy involves the administration of immunoglobulins to pregnant women to prevent or treat certain conditions in the fetus. This therapy leverages the immune system's components to provide passive immunity and is primarily used in cases where fetal or neonatal conditions could benefit from enhanced immune support.
